Institute for Behavioral Genetics, University of Colorado, Boulder, United States; Linda Crnic Institute, Anschutz Medical Center, Aurora, United States
Lauren LaPlante
Institute for Behavioral Genetics, University of Colorado, Boulder, United States
Bailey Keller
Institute for Behavioral Genetics, University of Colorado, Boulder, United States
Andrew Cooper-Sansone
Institute for Behavioral Genetics, University of Colorado, Boulder, United States
Curtis Borski
Institute for Behavioral Genetics, University of Colorado, Boulder, United States
Department of Integrative Physiology, University of Colorado, Boulder, United States
Marissa Ehringer
Institute for Behavioral Genetics, University of Colorado, Boulder, United States; Department of Integrative Physiology, University of Colorado, Boulder, United States
Institute for Behavioral Genetics, University of Colorado, Boulder, United States; Linda Crnic Institute, Anschutz Medical Center, Aurora, United States; Department of Integrative Physiology, University of Colorado, Boulder, United States
AKT is implicated in neurological disorders. AKT has three isoforms, AKT1/AKT2/AKT3, with brain cell type-specific expression that may differentially influence behavior. Therefore, we examined single Akt isoform, conditional brain-specific Akt1, and double Akt1/3 mutant mice in behaviors relevant to neuropsychiatric disorders. Because sex is a determinant of these disorders but poorly understood, sex was an experimental variable in our design. Our studies revealed AKT isoform- and sex-specific effects on anxiety, spatial and contextual memory, and fear extinction. In Akt1 mutant males, viral-mediated AKT1 restoration in the prefrontal cortex rescued extinction phenotypes. We identified a novel role for AKT2 and overlapping roles for AKT1 and AKT3 in long-term memory. Finally, we found that sex-specific behavior effects were not mediated by AKT expression or activation differences between sexes. These results highlight sex as a biological variable and isoform- or cell type-specific AKT signaling as potential targets for improving treatment of neuropsychiatric disorders.